Tongjitang Chinese Medicines Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 81.7 | 62.2 | 42.9 |
| Cost of Goods Sold | 28.2 | 20.7 | 17.6 |
| Gross Profit | 53.5 | 41.4 | 25.3 |
| Gross Profit Margin | 65.4% | 66.7% | 59.0% |
| SG&A Expense | 34.5 | 20.6 | 11.2 |
| Depreciation & Amortization | 2.4 | 1.7 | -- |
| Operating Income | 16.6 | 19.2 | 14.2 |
| Operating Margin | 20.3% | 30.9% | 33.0% |
| Nonoperating Income | 8.4 | 1.7 | 1.2 |
| Nonoperating Expenses | 1.4 | 1.6 | 1.1 |
| Income Before Taxes | 23.6 | 19.3 | 14.2 |
| Income Taxes | 0.2 | 2.1 | 0.5 |
| Net Income After Taxes | 23.5 | 17.2 | 13.7 |
| Continuing Operations | 23.5 | 17.2 | 13.7 |
| Discontinued Operations | -- | -- | 0.0 |
| Total Operations | 23.5 | 17.2 | 13.7 |
| Total Net Income | 23.5 | 17.2 | 13.7 |
| Net Profit Margin | 28.7% | 27.7% | 32.0% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |





